METHODS article
Front. Microbiol.
Sec. Infectious Agents and Disease
Volume 16 - 2025 | doi: 10.3389/fmicb.2025.1612354
This article is part of the Research TopicMechanisms and Innovations in Combating Intracellular InfectionsView all 3 articles
The Dictyostelium discoideum -Mycobacterium marinum infection model, a powerful high throughput screening platform for anti-infective compounds
Provisionally accepted
- Biochemistry Department, University of Geneva, Geneve, Switzerland
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Tuberculosis is among the world's deadliest diseases, causing approximately 2 million deaths annually. The urgent need for new antitubercular drugs has been intensified by the rise of drug-resistant strains. Despite recent advancements, most hits identified through traditional target-based screening exhibit limited efficacy in vivo. Consequently, there is a growing demand for whole-cell-based approaches that directly utilize hostpathogen systems. The Dictyostelium discoideum-Mycobacterium marinum host-pathogen system is a wellestablished and powerful alternative model system to study mycobacterial infections. In this article, the phenotypic host-pathogen protocol assay is presented here which relies on monitoring M. marinum during its infection of the amoeba D. discoideum. This assay is characterized by its scalability for high-throughput screening, robustness, and ease of manipulation, making it an effective system for compound screening. This system provides not only bacterial load readout via a bioluminescent M. marinum strain, but now also host survival and growth via a fluorescent D. discoideum strain enabling further host characterization by quantifying growth inhibition and potential cytotoxicity. Finally, the system was benchmarked with selected antibiotics and anti-infectives and calculated IC50s and MICs where applicable, demonstrating its capability to differentiate between antibiotics and anti-infective compounds.This methods paper introduces a robust, scalable, and high-throughput phenotypic host-pathogen assay based on the well-established Dictyostelium discoideum-Mycobacterium marinum system. In contrast to conventional target-based drug screening approaches, which often struggle to translate effectively in vivo, this platform directly monitors pathogen-host interactions, providing comprehensive insights into bacterial load, host survival, and potential cytotoxicity. By employing bioluminescent M. marinum and fluorescent D. discoideum strains, we validated the system using established antibiotics and anti-infective compounds, effectively distinguishing their effects through IC50 and MIC calculations.
Keywords: Anti-infectives, phenotypic screening, Mycobacterium marinum, Dictyostelium discoideum, high-throughput
Received: 15 Apr 2025; Accepted: 16 Jun 2025.
Copyright: © 2025 Nitschke, Hanna and Soldati. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Nabil Hanna, Biochemistry Department, University of Geneva, Geneve, Switzerland
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.